New York Urology Specialists is proud to offer standard-of-care, advanced prostate biopsy options with transperineal and transrectal approaches, as well as MRI-fusion prostate biopsy for men who need it. Elevated PSA may suggest increased risk of prostate cancer. A prostate biopsy is one way to determine whether elevated PSA is caused by prostate cancer.
For men with elevated PSA levels, an MRI of the prostate is frequently the next step.
If the prostate MRI reveals a suspicious lesion—typically scored as PI-RADS 3 or higher (PI-RADS 3+)—an MRI-fusion (or MRI-targeted) prostate biopsy is the recommended diagnostic tool. This advanced technique combines detailed MRI images with real-time ultrasound to precisely target suspicious areas, rather than relying on random sampling alone. Dr. Shteynshlyuger typically performs a standard biopsy plus a targeted prostate biopsy to improve prostate cancer detection.
MRI-fusion biopsy offers several evidence-based advantages for men with elevated PSA and a visible suspicious prostate lesion on MRI, including higher detection of clinically significant prostate cancer (the type of cancer that is more likely to metastasize and cause problems). Studies show it identifies 30–40% more clinically significant cancers (those likely to grow and require treatment) than standard biopsies when the MRI shows a suspicious lesion.
When considering MRI-fusion prostate biopsy, experience matters. Dr. Alex Shteynshyuger is a specialist in MRI-fusion biopsy with more than 15 years of experience. He performs both transperineal and transrectal biopsies and is recognized as one of the pioneers of MRI-fusion prostate biopsy in New York. As a fellowship-trained urologic oncologist, he has performed hundreds of prostate biopsies and offers comprehensive care for elevated PSA, prostate cancer diagnosis, and treatment.
If you have any questions, to schedule a consultation, please contact us or call/text: 1-646-663-5515.
